Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multidrug resistance: focus in hematology.

Haematologica - 1 Jan 2000

Carulli G, Petrini M

Abstract excerpt

The appearance of chemoresistance is the most relevant limitation of chemotherapy. It has been shown that multidrug resistance (MDR) is frequently related to the expression of a membrane glycoprotein (P-170). This protein is able to bind ATP and leads to decreased accumulation of structurally unrelated antineoplastic drugs extensively used in the management of hematological patients. The availability of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA
Share to Drug Resistance
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Membrane Glycoproteins

Share to Mutation

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 1980479

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multidrug resistance: focus in hematology.PMID 1980479Read ↗

The expression of multidrug resistance (MDR) molecule in acute leukemia and lymphoma.Semantic proximity Read ↗

[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].Semantic proximity Read ↗

Clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies.Semantic proximity Read ↗

What does Multidrug Resistance (MDR) Expression Mean in the Clinic?Semantic proximity Read ↗

[Multidrug resistance of malignant tumors].Semantic proximity Read ↗

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.Semantic proximity Read ↗

Clinical trials of agents that reverse multidrug resistance. A literature review.Semantic proximity Read ↗

Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review.Semantic proximity Read ↗

[Multiple drug resistance].Semantic proximity Read ↗

Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Semantic proximity Read ↗

[Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].Semantic proximity Read ↗

Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.